Kursprognose für Aptevo Therapeutics Inc (APVO)APVOAptevo Therapeutics Inc

Alphio's APVO stock price prediction model matches the current Aptevo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.25 (+0.92%). The 1-week path is $1.25 (+1.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aptevo Therapeutics is not a good buy right now due to its extremely low RSI of 19.049, indicating oversold conditions, and a staggering year-to-date change of -86.80%. The stock has significant financial challenges, including a reported EPS of -40.11, which is far below expectations. The main risk is its forward P/E of 3.8895, which suggests that while the stock may be undervalued, the company is struggling to generate revenue, as evidenced by total revenue of $0.00 for multiple quarters. The lack of positive cash flow and ongoing losses indicate that investors should be cautious before considering a purchase.

Aptevo Therapeutics Inc (APVO) last closed at $1.2399, losing -2.37%. These facts feed the 1-day and 1-week APVO price prediction above.